165 related articles for article (PubMed ID: 4387239)
1. Effect of beta adrenergic receptor blockade on skeletal muscle vasodilatation produced by isoxsuprine and nylidrin.
Manley ES; Lawson JW
Arch Int Pharmacodyn Ther; 1968 Sep; 175(1):239-50. PubMed ID: 4387239
[No Abstract] [Full Text] [Related]
2. Beta adrenergic blocking and cardiovascular properties of two new substances, Kö 1313 and Kö 1366.
Baum T; Rowles G; Shropshire AT; Gluckman MI
J Pharmacol Exp Ther; 1971 Feb; 176(2):339-49. PubMed ID: 4398186
[No Abstract] [Full Text] [Related]
3. Cardiovascular pharmacology of two new beta-adrenergic receptor antagonists.
Stanton HC; Kirchgessner T; Parmenter K
J Pharmacol Exp Ther; 1965 Aug; 149(2):174-82. PubMed ID: 4378559
[No Abstract] [Full Text] [Related]
4. Influence of acidosis on noradrenaline-induced vasoconstriction in adipose tissue and skeletal muscle.
Hjemdahl P; Fredholm BB
Acta Physiol Scand; 1976 Jul; 97(3):319-24. PubMed ID: 961443
[TBL] [Abstract][Full Text] [Related]
5. Pulmonary vascular and cardiac effects of glucagon before and after adrenergic beta-receptor blockade.
Madan BR; Gupta RS; Jain BK
Indian J Physiol Pharmacol; 1971 Oct; 15(4):173-7. PubMed ID: 4401547
[No Abstract] [Full Text] [Related]
6. Haemodynamic changes induced by intra-arterial injections of vasodilator substances in the muscle circulation of the dog limb with experimental femoral artery occlusion.
Lambert J; Lambert PJ
Angiologica; 1966; 3(3):153-67. PubMed ID: 4379951
[No Abstract] [Full Text] [Related]
7. Coronary vasodilation and adrenergic receptors.
Malindzak GS; Miller RD; Green HD
Arch Int Pharmacodyn Ther; 1972 Jan; 195(1):87-98. PubMed ID: 4622069
[No Abstract] [Full Text] [Related]
8. Some pharmacological properties of a new adrenergic beta-receptor antagonist.
Shanks RG; Wood TM; Dornhorst AC; Clark ML
Nature; 1966 Oct; 212(5057):88-90. PubMed ID: 4381648
[No Abstract] [Full Text] [Related]
9. Effects of beta-adrenergic blockade on the hemodynamic response to carotid sinus reflexes.
Lacroix E; Demeester G; Leusen I
Arch Int Pharmacodyn Ther; 1968 Oct; 175(2):447-63. PubMed ID: 5702960
[No Abstract] [Full Text] [Related]
10. The effects of beta-adrenergic receptor blockade on the blood pressure and heart rate changes induced by noradrenaline infusion and postinfusional hypotension.
Mazurkiewicz IM
Arch Int Pharmacodyn Ther; 1968 Jan; 171(1):136-58. PubMed ID: 4384633
[No Abstract] [Full Text] [Related]
11. Role of beta-receptor vascular tone in the vasodilating action of some drugs.
Yamamoto J; Maeda K; Kato S; Kobayashi K; Sekiya A
Jpn Circ J; 1973 Dec; 37(12):1427-31. PubMed ID: 4151932
[No Abstract] [Full Text] [Related]
12. The effect of beta-adrenergic blockade on coronary blood flow in the homografted canine heart.
Boake WC; Folts JD
Arch Int Pharmacodyn Ther; 1971 Jul; 192(1):96-104. PubMed ID: 4398413
[No Abstract] [Full Text] [Related]
13. The peripheral vascular effects of propranolol and related compounds.
Shanks RG
Br J Pharmacol Chemother; 1967 Feb; 29(2):204-17. PubMed ID: 4382235
[No Abstract] [Full Text] [Related]
14. Localization of beta-receptors in the circulatory tract.
Charbon GA; Reneman RS
Pflugers Arch; 1970; 314(2):168-9. PubMed ID: 4391471
[No Abstract] [Full Text] [Related]
15. A comparative study of the beta adrenergic blocking activities of propranolol and inpea.
Hahn RA; Pendleton RG; Wardell JR
J Pharmacol Exp Ther; 1968 May; 161(1):111-21. PubMed ID: 5648488
[No Abstract] [Full Text] [Related]
16. Influence of adrenergic beta-receptor blockade on the acute cardiovascular effects of hydralazine.
Brunner H; Hedwall PR; Meier M
Br J Pharmacol Chemother; 1967 May; 30(1):123-33. PubMed ID: 6039968
[No Abstract] [Full Text] [Related]
17. [Selective beta-blocking action of practolol (ICI 50.172)].
Novelli GP; Pagni E; Cortesini C; Pagliai P; Francini R
Minerva Anestesiol; 1969 Dec; 35(12):1286-94. PubMed ID: 4394406
[No Abstract] [Full Text] [Related]
18. A comparison of the adrenergic receptor blocking properties of 1-(4'-methylphenyl)-2-isopropylamino-propanol-HCl and propranolol.
Levy B
J Pharmacol Exp Ther; 1967 Jun; 156(3):452-62. PubMed ID: 6067476
[No Abstract] [Full Text] [Related]
19. Effect of o-2-hydroxy-3-(tert.-butylamino) propoxybenzonitrile HCl (KO 1366) on beta adrenergic receptors in the cardiovascular system.
Nayler WG; Tay J
J Pharmacol Exp Ther; 1972 Feb; 180(2):302-16. PubMed ID: 4400889
[No Abstract] [Full Text] [Related]
20. Adrenergic mechanisms in the initiation of cardiac arrhythmias.
Garvey HL
Arch Int Pharmacodyn Ther; 1969 Dec; 182(2):376-90. PubMed ID: 4391896
[No Abstract] [Full Text] [Related]
[Next] [New Search]
